FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+25.64%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.2B
AUM Growth
+$1.2B
(+5.4%)
Cap. Flow
-$84.4M
Cap. Flow
% of AUM
-7.02%
Top 10 Holdings %
Top 10 Hldgs %
47.68%
Holding
49
New
5
Increased
14
Reduced
19
Closed
11
Top Buys
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$31.5M |
| 2 |
Dyne Therapeutics
DYN
|
$31.4M |
| 3 |
Repligen
RGEN
|
$24.7M |
| 4 |
Evolent Health
EVH
|
$24.1M |
| 5 |
Kymera Therapeutics
KYMR
|
$19.2M |
Top Sells
| 1 |
LivaNova
LIVN
|
$38.9M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$31M |
| 3 |
Alphatec Holdings
ATEC
|
$28.9M |
| 4 |
Natera
NTRA
|
$23.4M |
| 5 |
Tactile Systems Technology
TCMD
|
$16M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $95M | 7.9% | 5,940,132 +1,159,572 | +24% | +$18.5M |
|
|
FNA
2
DELISTED
Paragon 28, Inc.
FNA
| $67.8M | 5.64% | 10,154,643 +1,979,811 | +24% | +$13.2M |
|
|
3
Evolent Health
EVH
$1.12B
| $65M | 5.41% | 2,298,261 +852,956 | +59% | +$24.1M |
|
4
Axogen
AXGN
$743M
| $57.3M | 4.77% | 4,090,296 +746,263 | +22% | +$10.5M |
|
5
AtriCure
ATRC
$1.84B
| $52.3M | 4.35% | 1,865,536 -99,167 | -5% | -$2.78M |
|
6
Insmed
INSM
$28.8B
| $50.3M | 4.18% | 688,910 +137,607 | +25% | +$10M |
|
7
Crinetics Pharmaceuticals
CRNX
$2.92B
| $48.2M | 4.01% | 943,611 -256,897 | -21% | -$13.1M |
|
8
Xenon Pharmaceuticals
XENE
$2.98B
| $46.5M | 3.87% | 1,181,662 -124,598 | -10% | -$4.91M |
|
9
NeoGenomics
NEO
$1.13B
| $45.4M | 3.78% | 3,076,555 -706,006 | -19% | -$10.4M |
|
|
10
Dyne Therapeutics
DYN
$1.92B
| $45.2M | 3.76% | 1,257,285 +874,852 | +229% | +$31.4M |
|
11
Tandem Diabetes Care
TNDM
$845M
| $43.5M | 3.62% | 1,025,307 +316,825 | +45% | +$13.4M |
|
12
Ultragenyx Pharmaceutical
RARE
$2.89B
| $41.9M | 3.49% | 755,102 -208,044 | -22% | -$11.6M |
|
|
PHLT
13
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $41.9M | 3.49% | 11,210,400 +696,200 | +7% | +$2.6M |
|
14
Transmedics
TMDX
$3.92B
| $41.7M | 3.47% | 265,734 -34,866 | -12% | -$5.47M |
|
15
Oscar Health
OSCR
$4.31B
| $37.5M | 3.12% | 1,765,892 -100,030 | -5% | -$2.12M |
|
16
Insulet
PODD
$23.9B
| $37M | 3.08% | 159,082 -56,555 | -26% | -$13.2M |
|
17
Health Catalyst
HCAT
$239M
| $35M | 2.91% | 4,296,490 +340,401 | +9% | +$2.77M |
|
18
AnaptysBio
ANAB
$569M
| $31.8M | 2.64% | 948,131 +168,973 | +22% | +$5.66M |
|
|
CDMO
19
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $31.5M | 2.62% | +2,771,853 | New | +$31.5M |
|
20
Vera Therapeutics
VERA
$1.38B
| $31.2M | 2.59% | 705,234 -300,489 | -30% | -$13.3M |
|
21
Pliant Therapeutics
PLRX
$101M
| $28.9M | 2.4% | 2,575,546 -825,667 | -24% | -$9.26M |
|
|
22
Repligen
RGEN
$6.88B
| $24.7M | 2.05% | +165,873 | New | +$24.7M |
|
|
23
Natera
NTRA
$23.1B
| $23.5M | 1.95% | 184,939 -184,129 | -50% | -$23.4M |
|
24
Structure Therapeutics
GPCR
$1.11B
| $22.2M | 1.85% | 506,222 -84,425 | -14% | -$3.71M |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$511M
| $21.9M | 1.82% | 967,006 -417,762 | -30% | -$9.45M |
|